
Glucagon-secretin peptide superfamily member
VIP (Vasoactive Intestinal Peptide)
Glucagon-secretin peptide superfamily member. Supplied for laboratory research use only.
- Aviptadil; holds FDA Fast Track, Orphan Drug status for several uses
- Phase 3 COVID trial (n=471) halted for futility
- FDA moving to remove its only lawful compounding route
- Supplied for laboratory research use only. Not for human or veterinary use.
90-Day Money-Back Guarantee
Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.
Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.
What it is
Development status
VIP is not approved by the FDA for any indication.
Aviptadil holds FDA Fast Track and Orphan Drug designations for several respiratory indications. Neither is an approval. Its most advanced trial, intravenous aviptadil for severe COVID-19 respiratory failure, was halted for futility at 471 participants. That is a negative trial outcome, not an absence of data.
Shipping & returns
The specifics
The details, if you want them.
Development
Where it is up to.
Phase 1 and Phase 2 trials are complete. Holds FDA Fast Track and Orphan Drug designations for several indications — designations, not approvals.
Questions
The questions people actually ask.
What is VIP?
Is VIP approved by the FDA?
What does "Research Use Only" mean?
How is VIP supplied?
What is your refund policy?